Biotech

All Articles

Bicara, Zenas seek IPOs to drive late-phase possessions towards market

.Bicara Therapeutics and also Zenas Biopharma have provided new incentive to the IPO market with fil...

Genentech to finalize cancer cells immunology investigation division

.Genentech will certainly shut its own cancer immunology research division, and also unit mind and a...

Kezar drops sound lump but to prove its own worth in stage 1 test

.Kezar Life Sciences is actually falling its unpromising phase 1 strong lump medication as the biote...

Acelyrin falls izokibep, drops 3rd of personnel

.In spite of izokibep preserving its own newly found winning touch in the facility, Acelyrin is actu...

Rivus' stage 2 obesity-related heart failure trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its fat-busting, muscle-sparing medicati...

Ovid halts preclinical job, IV program after soticlestat stop working

.Ovid Therapy actually exposed final month that it was actually trimming its headcount as the compan...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has actually opened a $700 thousand R&ampD facility in the Boston Seaport, improving its ...

Boundless Bio helps make 'moderate' layoffs five months after $100M IPO

.Just 5 months after securing a $one hundred million IPO, Limitless Biography is actually presently ...

Halda's $126M will definitely advance 'secure and also get rid of' growth drugs

.The first stages of oncology R&ampD aren't short of interesting brand new methods, as well as Halda...

Lykos 'disappointments' certainly not revealing study transgressions with publisher

.Psychopharmacology has actually drawn three write-ups regarding midstage medical trial data determi...